10. Microvascular Complications and Foot Care: <i>Standards of Medical Care in Diabetes—2018</i>

,

doi:10.2337/dc18-s010

Cited by 247 publications

(109 citation statements)

References 143 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is a fundamental step before more widespread use of the ABI in the clinical management of type 2 diabetes can be recommended. Currently, the ADA only recommends ABI measurement in individuals with symptoms (intermittent claudication) or signs (decreased pedal pulses) of PAD [29]. Finally, as far as we know, no previous studies have addressed the importance of the ABI as a risk marker for future microvascular complications, except for foot ulceration/amputation, although several cross-sectional analyses have reported associations between a reduced ABI and the prevalence of microvascular complications [30][31][32][33].…”

Section: Introductionmentioning

confidence: 99%

Prognostic impact of the ankle–brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Prognostic impact of the ankle–brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study

et al. 2018

View full text Add to dashboard Cite

show abstract

“…[15]. Классификация ДР приведена соответствует рекомендациям Международного совета по офтальмологии (International Council of Ophthalmology) и Американской Диабетологической Ассоциации (American Diabetes Association) [16,17].…”

Section: Discussionunclassified

Trends in the epidemiology of diabetic retinopathy in Russian Federation according to the Federal Diabetes Register (2013–2016)

Lipatov¹,

Vikulova²,

Zheleznyakova³

et al. 2018

Diabetes mellitus

View full text Add to dashboard Cite

Background: Diabetic retinopathy (DR) is one of the most common causes of blindness in patients with diabetes mellitus (DM) that is why its necessary to study the epidemiological characteristics of this complication. Aims: The aim of the study was to evaluate the epidemiological characteristics of DR and blindness in adult patients with type 1 (T1) and 2 (T2) diabetes in Russian Federation (RF) for period 201316years. Materials and methods: Database of Federal Diabetes register, 81st regions included in the online register. Indicators were estimated per 10,000 adult DM patients (18years). Results: In 2016 the DR prevalence in RF was T1 38,3%, T2 15,0%, with marked interregional differences: 2,666,1%, 1,146,4%, respectively. The DR prevalence within 20132016 years was: T1 3830,93805,6; T2 1586,01497,0. Trend of new DR cases/per year increased: T1 153,2187,8; T2 99,7114,9. The structure of new cases of DR in 2016: non-proliferative stage (T1 71,4%, T2 80,3%), pre-proliferative stage 16,4%, 13,8%, proliferative 12,1%, 5,8%, terminal 0,2%, 0,1%, respectively, these data indicated the earlier detection of DR. The mean age of DR diagnosis increased: T1 by 1,2 years, T2 by 2,6. The average DM duration of DR determine increased T1 9,613,1 years, T2 6,09,1. The prevalence of blindness tends to decrease: T1 92,390,8; T2 15,415,2/10.000 DM adults. The amount of new cases of blindness/per year increased: T1 4,34,6; T2 1,21,4. The mean age of blindness increased: T1 39,141,6 years, T2 64,467,4; the mean duration of diabetes before blindness occur (from the time of DM diagnosis) increased: T1 20,221,2 years, in T2 10,711,3. We observed growth of DR treatment (laser surgery, vitrectomy, anti-VEGF medication) but the frequency of use in T2 patients is about 2 times less than in T1. Conclusions: There was a decrease in the overall incidence of eye damage in diabetes (DR and blindness) in the analyzed period in RF. DR and blindness develops at advanced age and with a longer duration of diabetes. As the main directions of eye care development in diabetes it is necessary to standardize primary care in the regions, to unify the examination algorithms and methods of early diagnostic, to increase the continuity and interaction of endocrinologists and ophthalmologists in managing patients with diabetes in order to prevent the development of new cases of vision loss.

show abstract

“…25,26 However, in Italy, no national screening programme has been Diabetologists (AMD). 29 We proposed to optimize the current guidelines for the screening, diagnosis, and treatment of retinopathy in the diabetic patient and to establish a valid basis for future studies on this topic.…”

Section: Evaluation Of Dr Prevalence By Retinographymentioning

confidence: 99%

Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study

Sasso

Pafundi

Gelso

et al. 2019

Diabetes Metabolism Res

View full text Add to dashboard Cite

Aims Diabetic retinopathy (DR) represents the main cause of blindness among adults in the industrialized Countries. Use of telemedicine could offer an easy, smart specialist fundus oculi examination, as well as putting in a screening programme many patients who otherwise would be excluded. Materials and methods The NO BLIND is a transversal, multicentre, observational study. Its pilot phase involved nine public outpatient clinics for 6 months. As endpoint of the study, we assessed the prevalence of DR by retinography in a subset of the Italian population. Patients' fundus oculi photos were performed by trained diabetologists through a digital smart ophthalmoscope. Results According to our endpoint, in the final study population (n = 1461), obtained excluding patients for whom retinography was not able to provide any diagnosis, DR prevalence was equal to 15.5%. According to the receiver operating characteristic (ROC) curve performed, we can observe how retinography appears a highly accurate method to detect DR (AUROC 0.971, 95% confidence interval, 0.954‐0.989), with a specificity of the 100% and a sensitivity of the 94.3%. Conclusions Our findings, in an Italian setting, confirm main data in the literature about DR prevalence. Hence, telemedicine could represent an accurate, fast, and cheap method for screening of DR.

show abstract

10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018

Cited by 247 publications

References 143 publications

Prognostic impact of the ankle–brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study

Prognostic impact of the ankle–brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study

Trends in the epidemiology of diabetic retinopathy in Russian Federation according to the Federal Diabetes Register (2013–2016)

Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study

Contact Info

Product

Resources

About